IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,957,656 | -28.0% | 3,287,397 | +11.4% | 3.99% | -4.5% |
| Q2 2023 | $20,768,831 | +30.0% | 2,950,118 | +12.8% | 4.18% | +0.7% |
| Q1 2023 | $15,977,509 | +16.3% | 2,614,977 | +21.7% | 4.15% | +16.5% |
| Q4 2022 | $13,735,625 | -15.7% | 2,149,550 | +26.4% | 3.56% | -7.6% |
| Q3 2022 | $16,286,000 | +22.9% | 1,700,000 | +41.7% | 3.86% | +4.8% |
| Q2 2022 | $13,248,000 | – | 1,200,000 | – | 3.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |